Medical/Psychiatric Comanagement by Nurse Practitioners in Chronic Hepatitis C Treatment: A Case Study

References 

1. Annemans L, Warie H, Nechelput M, Peraux B. A health economic model to assess the long term effects and cost-effectiveness of PEG IFN alpha-2a in hepatitis C virus infected patients. Acta Gastro-Enterologica Belgica. 2004;67(1):1–8
   • MEDLINE
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine. 2006;144(10):705–714
3. Brunette MF, Mueser KT. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder. Journal of Clinical Psychiatry. 2006;67(Suppl 7):10–17
4. Consensus Conference Statement on the Management of Hepatitis C. (2002). Bethesda, MD: US Department of Health and Human Services.
5. Friedmann, E., Thomas, S. A., Liu, F., Morton, P. G., Chapa, D., & Gottlieb, S. S. (2006). Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. American Heart Journal 152(5), 940, e941–e948.
6. Gardenier D, Alfandre D. Primary care of the patient with chronic hepatitis C. Journal for Nurse Practitioners. 2006;2(8):517–524
7. Gardenier D, Alfandre D, Schiano T, O'Connor-Moore N, McGinn TG. Primary care based hepatitis C treatment: Collaborating to improve access, adherence and outcomes. Hepatology. 2005;42(4 (suppl 1)):675
   • MEDLINE
   • CrossRef
8. Goldberg RW. Supported medical care: A multi-faceted approach to helping HIV/hepatitis C virus co-infected adults with serious mental illness. AIDS. 2005;19(Suppl 3):S215–S220
9. Hepatitis C Fact Sheet No. 164. (2000). Geneva: World Health Organization.
10. Herrine SK. Approach to the patient with chronic hepatitis C virus infection. Annals of Internal Medicine. 2002;136(10):747–757
11. Huckans MS, Blackwell AD, Harms TA, Hauser P. Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders. Psychiatric Services. 2006;57(3):403–406
12. Knott A, Dieperink E, Willenbring ML, Heit S, Durfee JM, Wingert M, et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: Effect on antiviral treatment evaluation and outcomes. American Journal of Gastroenterology. 2006;101(10):2254–2262
13. Larson AM, Carithers RL. Hepatitis C in clinical practice. Internal Medicine Journal. 2001;249(2):111–120
14. McGinn TG, Gardenier D, McGinn LK, Alfandre D, O'Connor N, Sturm T, et al. Treating chronic hepatitis C in the primary care setting. Seminars in Liver Disease. 2005;25(1):65–71
    • MEDLINE
    • CrossRef
15. Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. Journal of General Internal Medicine. 2005;20(8):754–758
    • CrossRef
16. Ouwens M, Wollersheim H, Hermens R, Hulscher M, Grol R. Integrated care programmes for chronically ill patients: A review of systematic reviews. International Journal for Quality in Health Care. 2005;17(2):141–146
17. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis management and treatment of hepatitis C. Hepatology. 2004;1147–1171
18. Sturm TM, Federman A, Wisnivesky J, McGinn TG. Hepatitis C prevalence and risk factors in an urban primary care practice. Journal of General Internal Medicine. 2004;19(supp1):157
19. Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance use disorders: Concepts and approaches. AIDS. 2005;19(Suppl 3):S227–S237